Summary

The adoptive transfer of autoreactive S100β-specific T cells cell lines all exhibited a CD4ϩ, CD8-, T-cell receptor αβϩ surface phenotype and secreted tumour necrosis factor-α, induces experimental autoimmune panencephalomyelitis and interferon-γ, interleukin-10 and interleukin-4 upon antigenic uveoretinitis in the Lewis rat, mimicking the distribution of stimulation, but they were heterogenous with respect to T-cell lesions seen in a subset of patients with multiple sclerosis. We receptor usage; two T-cell lines expressed Vβ2, one Vβ 6.7 and studied the frequency and functional properties of the human
one Vβ 13. Antigen-specificity was confirmed using bovine T-cell response to S100β in eight patients (two relapsing-S100ββ and αβ-isoforms, as well as a recombinant rat S100β remitting multiple sclerosis, one chronic-progressive multiple preparation. The response to S100β was shown to be HLAsclerosis, two with multiple sclerosis and uveitis, two ( 
human leukocyte antigen-) DR-restricted for two of the S100β-neuromyelitis optica, one panuveitis) and in seven healthy specific T-cell lines. Human S100β-specific T-cell lines were individuals, using bovine S100β for T-cell stimulation. Both in cytotoxic, although to a lesser extent than MBP-specific Tpatients and controls, the frequency of S100β-specific T-cell cell lines derived from the same donors. The phenotypic and responses was half of that obtained for myelin basic protein functional properties of human S100β-specific T-cell lines raise (MBP), and only 10% of that obtained using purified protein the possibility that these T cells are pathogenic, as they are in derivative (PPD). The stimulation indices obtained in response the rat. The low frequency and proliferative index of S100β-to S100β were also less than half those obtained with either specific, as opposed to MBP-specific T-cell responses suggests MBP or PPD. However, four long-term S100β-specific T-cell that the T-cell response to this widely expressed calciumbinding protein is under more efficient regulatory control.
Introduction
Human myelin basic protein (MBP)-specific T cells share (EAE) in rodents. In both species CD4ϩ T cells specific for MBP are cytotoxic in vitro and secrete proinflammatory many features with encephalitogenic MBP-specific T cells that cause experimental autoimmune encephalomyelitis cytokines such as interferon (IFN)-γ, tumour necrosis factor (TNF)-α and interleukin (IL)-2 (Antel et al., 1985; according to Poser et al. (1983) , and neuromyelitis optica according to Mandler et al. (1993) . Wucherpfennig et al., 1991; Martin et al., 1992; Hohlfeld et al., 1995) . For many years MBP was considered as the most important or even only candidate autoantigen in multiple sclerosis. This view has changed following the demonstration
Antigens
Bovine S100β (ββ) and phytohaemagglutinin (PHA) were that T cells specific for other myelin components such as proteolipid protein (PLP), myelin-associated glycoprotein purchased from Sigma (Deisenhofen, Germany), bovine S100 (αβ) from Calbiochem/Novabiochem (Bad Soden, Germany), (MAG) and myelin oligodendrocyte glycoprotein (MOG) are also encephalitogenic (Wekerle et al., 1994) . Intriguingly, the purified protein derivative of tuberculin (PPD) from Statens Institut (Copenhagen, Denmark), and tetanus toxoid from lesional topography and histopathology of these new models of EAE are dependent on the identity of the target autoantigen Behringwerke (Marburg, Germany). MBP was purified according to established protocols (Eylar et al., 1979) . Purity (Wekerle et al., 1994; Lassmann and Vass, 1995) suggesting that the diversity of lesional distribution observed in multiple of the MBP and S100 preparations was assessed by gel electrophoresis. Antigens were used at the following sclerosis may be explained by differences in the antigenspecificity of the pathogenic autoimmune responses.
concentrations: S100β (ββ) and S100 (αβ), 50 µg/ml; MBP, 30 µg/ml; PPD, 20 µg/ml; tetanus toxoid, 4 µg/ml; PHA, The spectrum of candidate autoantigens able to induce an encephalitogenic T-cell response was recently further 5 µg/ml. extended to include S100β, a major calcium-binding nonmyelin protein abundantly expressed in astroglia (Kojima et al., 1994) . In addition, S100β is expressed in the peripheral
Recombinant rat S100β
S100β genes of rat brain cDNA were amplified using the nervous system and in many other cells and tissues, including retina, skeletal muscle, adipose tissue, salivary gland, and following primers: coding strand, 5Ј-CGAAGATCTG-AGCTGGAGAAGGCC; complementary strand, 5Ј-GGAimmune cells (Zimmer, 1995) . In the Lewis rat, the adoptive transfer of S100β-specific T-cell lines induces a severe AGATCTCTCATGTTCAAAGAACTCATGA. The PCRprimers contained BglII restriction sites to allow subsequent inflammatory response in the nervous system, experimental autoimmune panencephalitis (EAP) (Kojima et al., 1994) .
ligation into the expression vector pQE-12 (Qiagen, Düsseldorf, Germany). The rat S100β molecule was thus EAP offers several parallels with multiple sclerosis that are not seen in models of EAE induced by MBP-specific T extended for the amino acids (Met)-Arg-Gly-Ser-Arg-Ser at its N-terminus, and for Arg-Ser-(His) 6 at its C-terminus. cells. In the S100β paradigm, clinical disease was minimal, although the intensity of the inflammatory response was Escherichia coli strains JM109 and M15-pREP4 were transfected, and induced with 1 mM isopropylthiogalactoside similar to that which would prove lethal in rats with MBPinduced EAE. This difference in the pathogenicity of S100β-(Sigma, St Louis, OH, USA). Transfected bacteria were harvested, centrifuged, pulse sonicated, and resuspended in specific T-cell lines correlates with their lack of cytotoxic activity in vitro and a decreased recruitment of macrophages lysis buffer (200 ml of 6 M urea, 0.5 M NaCl and 100 mM sodium acetate buffer at pH 6.0). The supernatant was then (Kojima et al., 1994) . Moreover, unlike EAE models initiated by the adoptive transfer of myelin-specific T cells, S100β-applied to a 10-ml chelating Sepharose fast flow column (Pharmacia Biotest Europe, Freiburg, Germany) previously specific T cells induce an intense, acute inflammatory response in the uvea and the retina of the eye, as well as in loaded with NiCl 2 and equilibrated in urea-containing buffer. The column was washed and eluted with a sodium acetate the CNS (Kojima et al., 1994) . These pathological changes in the eye are reminiscent of those reported in a substantial gradient from pH 6.0 to 3.0 in 6 M urea and 0.5 M NaCl. The recombinant protein was dialysed against distilled water, proportion of multiple sclerosis patients (Bamford et al., 1978; Lightman et al., 1987; Shaw et al., 1987) , prompting ethanol-precipitated and resuspended in phosphate-buffered saline. Recombinant rat S100β was used at a concentration us to analyse the human T-cell response to S100β with special regard to patients with multiple sclerosis and of 100 µg/ml. coexisting uveitis, or other atypical presentations of inflammatory demyelinating diseases of the CNS.
Isolation of antigen-specific T-cell lines
S100β-specific T-cell lines were generated using the 'splitwell' primary limiting dilution technique (Pette et al., Material and methods 1990a, b) . Briefly, peripheral blood mononuclear cells (PBMCs) were prepared from heparinized blood samples by
Patients and normal subjects
Blood samples were taken from eight patients and seven Ficoll (Nycomed, Oslo, Norway) standard density gradient centrifugation. PBMC were cultured with purified bovine healthy controls. Sex, age, human leukocyte antigen (HLA)-types and clinical details are listed in Tables 1A and 1B . S100β in 200 µl RPMI 1640 supplemented with 2 mM Lglutamine, 100 U/ml penicillin G, 100 µg/ml streptomycin Patients were coded P1, P2, etc. and normal subjects were coded N1, N2, etc. Multiple sclerosis was diagnosed (all from Gibco, Berlin, Germany) and 5% pooled human Course of disease: HLA ϭ human leukocyte antigen; PCP ϭ primary chronic progressive; RR ϭ relapsing-remitting; SCP ϭ secondary chronic progressive. *Laboratory-supported definite multiple sclerosis (MS) (Poser et al., 1983) . † Diagnosed according to Mandler et al. (1993) . ‡ Laboratory-supported probable MS (Poser et al., 1983) . AB serum in 96-well round bottom microtitre plates (Nunc, subjects (six patients, four normal subjects) using the 'split well' protocol as described above. In each individual donor, Roskilde, Denmark) at 2 ϫ 10 5 cells per well. Every 3-4 days the cells were fed with 100 µl medium containing 5U 60 T-cell lines were raised against each of the three antigens, S100β, MBP and PPD, and screened for antigen-specific recombinant IL-2 (Boehringer Mannheim, Germany). After 14 days the content of each well was split between two reactivity measured as 3 H-incorporation. Stimulation indices (SI) were calculated as the proliferative response in the wells. 2 ϫ 10 5 autologous irradiated (5000 rad) PBMC were added to both wells. S100β was added to one well, while presence of antigen, divided by the proliferative response in the absence of antigen. Specific proliferation to S100β, MBP the other well did not receive antigen. After 48 h the cultures were scanned microscopically for S100β-specific and PPD was assumed if the SI was Ͼ2 and the absolute counts were Ͼ500 c.p.m. in the antigen-containing wells. In proliferation, and specifically responding populations were selected for expansion.
addition, a mean SI was determined for each antigen, calculated as total sum of SI divided by the number of specific T-cell lines.
Proliferation assay
Duplicate or triplicate wells containing 5 ϫ 10 4 T-line cells and 2 ϫ 10 5 irradiated (5000 rad) autologous PBMC were MHC-restriction of S100β-and MBP-specific Tincubated in the presence or absence of antigen. Cells were cell lines cultured for 72 h, and 0.2 µCi (Amersham, Braunschweig, The major histocompatibility complex (MHC) restriction of Germany) was added for the last 18 h. Cells were harvested, MBP-and S100β-specific T-cell lines was determined using and [ 3 H]thymidine incorporation was measured using a direct blocking monoclonal antibodies (mAbs), i.e. L243 (anti-β-counter (Matrix TM 96 Direct Beta Counter; Packard, DR; ATCC, Rockville, Md, USA), mAb SPVL3 (anti-DQ; Frankfurt, Germany) that yields~20% of the counts obtained Immunotech, Marseille, France), and mAb HB145 (antiwith liquid scintillation counting.
DR, -DQ, -DP; ATCC). The MHC class I specific mAb W6/ 32 (ATCC) and a polyclonal goat anti-rat IgG antibody (Dianova, Hamburg, Germany) were used as controls.
Estimation of relative frequencies of S100β-,
Autologous irradiated (5000 rad) antigen-presenting cells
MBP-and PPD-specific T-cell lines in
(APCs) (2 ϫ 10 5 cells per well) were pulsed with the blocking mAbs in a final concentration of 5-10 µg/ml for 30 min at
individual donors
A comparative frequency analysis of S100β-, MBP-and 37°C. APC were then pulsed with MBP or S100β for another 3 h, T-line cells (5 ϫ 10 4 ) were added for 72 h, and PPD-specific short-term T-cell lines was performed in 10 proliferation was measured as In initial experiments, we stimulated PBMC with increasing irradiated (20 000 rad) Epstein-Barr virus-transformed Bconcentrations of S100β. No significant toxicity could be cells (1 ϫ 10 5 ) were used as the APCs. Proliferation was detected using concentrations of up to 100 µg/ml as measured measured as [ 3 H]thymidine incorporation.
by [ 3 H]thymidine incorporation. Dose-response experiments with S100β-specific T-cell lines (see below) indicated that 50 µg/ml is the optimal concentration of S100β for use in
Cytotoxicity assays
proliferation assays (not shown). Cytotoxicity of S100β-and MBP-specific T-cell lines was
Relative frequencies of antigen-reactive T-cell lines were compared in standard 51 Cr-release assays. T-line cells were determined in six patients and four normal subjects using the used between 8 and 10 days after restimulation. Briefly, 'split-well' protocol (Table 2) . Only 29 of 600 T-cell lines autologous irradiated (5000 rad) monocytes (1 ϫ 10 6 ) were screened for S100β reactivity were specific. Moreover, in incubated with 100 µCi Na 2 51 CrO 4 (in a total volume of 1 ml three patients (P1, P6 and P8) and one healthy donor (N6), in a siliconized tube) for 2 h. After washing, cells were plated no S100β-specific response could be observed. In contrast, in flat-bottomed 96-well microtitre plates at a concentration of MBP-specific responses were observed in all donors, proving 10 4 cells per well. After 2 h, the cells were washed again, positive in 54 out of the 600 lines screened. The frequency and T-line cells were added at effector : target ratios of of PPD-specific responses was even higher, in that 492 out 1 : 1, 3 : 1, and 10 : 1 for 6 h. All assays were performed of the 600 lines tested were positive. Thus, PPD-specific Tin triplicate. Maximal isotope release was induced with 10% cell lines were detected at a 10-fold higher frequency than sodium dodecyl sulphate. The mean percentage specific MBP-specific T-cell lines, and MBP-specific T-cell lines were cytotoxicity was calculated as follows: (the mean twice as frequent as S100β-specific T-cell lines. When experimental release minus the mean background release)/ calculating the mean SIs for the three antigens tested, further (the mean maximal release minus the mean background differences became evident. The mean SI in S100β-specific release). Spontaneous release was~30% of maximal release.
T-cell lines was 3.2 Ϯ 1.2, whilst it was 7.9 Ϯ 3.8 in MBPspecific T-cell lines and 7.9 Ϯ 3.7 in PPD-specific T-cell lines ( Table 2) .
Characterization of T-cell lines by flow cytometry Phenotype, T-cell receptor usage and specificity
For phenotypical analysis we used fluorescein isothiocyanate (FITC)-labelled murine mAbs recognizing CD3, CD4, CD8
of S100β-specific T-cell lines
Ten S100β-specific long-term T-cell lines were generated and HLA-DR (Becton Dickinson, Heidelberg, Germany). FITC-labelled murine IgG1 and IgG2a mAbs (Becton from the peripheral blood of two normal subjects (n ϭ 2), two patients with relapsing-remitting multiple sclerosis (n ϭ Dickinson) served as controls. Cytofluorographic analysis of the T-cell receptor V-region expression was performed 4), one patient with multiple sclerosis and concomitant uveitis (n ϭ 2), and one patient with panuveitis (n ϭ 2) using the utilizing mAbs recognizing a pan-αβ T-cell receptor determinant (Immunotech), and T-cell receptor gene products 'split-well' technique. All T-cell lines expressed the CD4ϩ, CD8-, T-cell receptor α/βϩ phenotype. Four T-cell lines of the subfamilies Vβ3.1, Vβ5.1, Vβ5.2, Vβ5.3, Vβ6.7, Vβ8, Vβ12 and Vβ13 (T-cell Diagnostics, Woburn, Mass., USA), could be expanded for more detailed characterization of Tcell receptor usage, specificity, HLA-restriction, cytotoxicity and Vβ12.1. Vβ2, Vβ3, Vβ13.3, Vβ16, Vβ17, Vβ18, Vβ21.3 and Vβ22 (Immunotech, Marseille, France). FITC-labelled and cytokine profiles. The S100β-specific T-cell lines used different T-cell by Ͼ90% with the anti-HLA-DR mAb L243 (examples receptors. Two T-cell lines expressed Vβ2 (N2.40 and shown in Fig. 1 ). The other two S100β-specific T-cell lines P1.S100β), one Vβ6.7 (N1.20) and one Vβ13 (P2.S100/12) (N2.40, P1.S100β) could not be blocked with either anti-T-cell receptor gene products. All T-cell lines selected with MHC class II (anti-HLA-DR, -DQ, -DP) or by anti-MHC bovine S100β (ββ) cross-reacted with bovine S100 αβ class I mAb (one example [P1.S100β] is shown in Fig. 1 ), isoform (Table 3) . Furthermore, two of the four T-cell lines nor could the MHC restriction be established by using HLA-(N2.40 and N1.20) proliferated in response to a recombinant DR-transfected Epstein-Barr virus-transformed B cells nor rat S100β preparation (Table 3) . Bovine and human S100β DR-transfected L cells as APCs. differ in three of 91 aminoacids (positions 7, 62 and 80); rat
In contrast, fine MHC-restriction mapping with Epsteinand human S100β differ in two positions (positions 62 and Barr virus-transformed B-cell lines and HLA-DR-transfected 78; Zimmer et al., 1995) . The two S100β-specific T-cell lines L-cells revealed that the restriction element for the T-cell that cross-reacted with recombinant rat S100β did not react lines derived from donor N1 (N1.20) was DRB1 * 1501, the with synthetic rat S100β peptides representing the regions in same as for an MBP-specific T-cell lines (N1.BP24) obtained which the human and rat S100β sequences differ (peptide from the same donor. This provided us with a matched pair data not shown). Thus, at least the two cross-reactive T-cell of T-cell lines of identical phenotype and restriction for further lines (N2.40 and N1.20) react to determinants shared between analysis of their cytokine pattern and in vitro cytotoxicity. human, rat and bovine S100β.
In three donors, it was possible to isolate both S100β-and MBP-specific T-cell lines, so that the properties of autologous Cytotoxicity and cytokine production S100β-and MBP-specific T-cell lines could be directly
The cytotoxicity of the S100β-specific T-cell line N1.20 was compared.~5 0% of that of the matched MBP-specific T-cell line (N1.BP24) at an effector : target ratio of 3 : 1 in a standard 51 Cr-release assay (Fig. 2) . A similar difference in
MHC-restriction
the cytotoxicity of S100β and MBP-specific T-cell lines was Antigen-specific proliferation of all MBP-and two S100β-specific T-cell lines (N1.20 and P2.S100/12) could be blocked also observed in Patient P1 in whom no MHC class II Fig. 1 Differential restriction pattern of S100β-specific T-cell lines in individual donors. In multiple sclerosis patient P2, both the MBP-specific T-cell line P2.BP8 and the S100β-specific T-cell line P2.S100/12 could be blocked by preincubation of APCs with the anti-DR mAb L243 (A). In contrast, in multiple sclerosis patient P1, the S100β-specific T-cell line P1.S100β could not be blocked by either class I or II anti-MHC mAb, whilst the MBP-specific T-cell line P1.BP2(10) could be blocked by anti-DR mAb L243 (B). TdR ϭ thymidine uptake.
restriction could be demonstrated for the S100β-specific Tastroglia in the CNS. In addition, S100β is widely expressed in many other tissues including retina, peripheral nerve, cell line P1.S100β (Fig. 2) . At a 10-fold higher effector: target-cell ratio this difference in cytotoxicity was less skeletal muscle, adipose tissue, salivary gland, and immune cells (reviewed by Zimmer, 1995) . pronounced.
Both MBP-and S100β-specific T-cell lines secrete TNFIntriguingly, a similar population of S100β-specific T cells are highly encephalitogenic in the Lewis rat (Kojima et al., α, IFN-γ, IL-4 and IL-10 upon antigen stimulation. There was, however, no systematic difference in cytokine profiles 1994). Moreover, in the animal model S100β-specific T cells cause an inflammatory response not only in the CNS but between MBP-specific and S100β-specific T-cell lines obtained from the same donor (Table 4) . also in the uvea and retina (Kojima et al., 1994) . This is of both clinical and immunological interest, as a subpopulation of multiple sclerosis patients develop uveitis together with inflammatory CNS disease (Bamford et al., 1978; Shaw et al., 
Discussion
Our study demonstrates for the first time that autoreactive T 1987), and asymptomatic inflammatory changes of the retina ('periphlebitis retinae') can be found in up to 20% of multiple cells specific for S100β can be recovered from the immune repertoire of both normal subjects and patients with multiple sclerosis patients using immunofluorescence angiography (Shaw et al., 1987) . The risk of patients with optic neuritis sclerosis, or multiple sclerosis with uveitis. S100β is a major calcium-binding nonmyelin protein abundantly expressed in to progress to clinically definite multiple sclerosis correlates Fig. 2 Differential cytotoxicity of MBP-and S100β-specific T-cell lines in individual donors in a standard 51 Cr release assay as described in the Material and methods section. In multiple sclerosis patient P1, the S100β-specific T-cell lines P1.S100β is less cytotoxic than the autologous MBP-specific T-cell lines P1.BP2(10) (left). Similarly, in the healthy subject N1, the HLA-DRB1*1501 restricted S100β-specific T-cell lines N1.20 exhibits less cytotoxicity than the DRB1*1501 restricted MBP-specific T-cell lines N1.BP24 (right). The differential cytotoxicity is most marked at an effector : target ratio of 3 : 1. with retinitis (Lightman et al., 1987) . These clinical peptides representing the S100β regions in which the human and rat sequences differ. Thus, at least the two cross-reactive observations parallel histopathological studies demonstrating that although multiple sclerosis lesions are typically located T-cell lines react to determinants shared between human, rat and bovine S100β. Further experiments with a larger number in the periventricular white matter, optic nerves, cerebellar peduncles and spinal cord, inflammatory changes can also of human S100β-specific T-cell lines will be necessary to establish whether there exist any immunodominant epitopes be seen in nonmyelinated tissues such as the uvea and retina (Lassmann, 1983) . Thus, S100β should be considered a in the human S100β molecule. In the present study, although we demonstrated the presence potential target autoantigen in multiple sclerosis, especially in those multiple sclerosis patients exhibiting uveitis or retinal of S100β-specific T cells in the immune repertoire, we could not detect significant differences in the frequencies of inflammation.
Table 4 Cytokine production of S100β-and MBP-specific T-cell lines (TCLs) in individual donors
We used purified bovine S100β for stimulation of T cells. circulating S100β-specific T cells in patients and healthy controls. This is not suprising as tissue-specific autoreactive Bovine and human S100β differ in three of 91 aminoacids, namely those in positions 7, 62 and 80 (Zimmer et al., 1995) .
T cells have been firmly established as a constitutive component of the normal immune system (Wekerle, 1992). Rat and human S100β differ in two positions (62 and 78). Two of our S100β-specific T-cell lines cross-reacted with Similar results have been reported for the major myelin derived autoantigens, MBP and PLP (Hafler et al., 1987 ; recombinant rat S100β, but not with synthetic rat S100β Chou et al., 1992; Meinl et al., 1993; Markovic-Plese et al., restriction element (DRB1*1501) suggesting that the lower degree of cytotoxicity directly depends on the antigen-1995). Furthermore, even in myasthenia gravis where the autoantigen has been firmly established as the nicotinic specificity of the TCL. In contrast to MBP-specific T-cell lines, only two S100β-acetylcholine receptor, the frequency of circulating acetylcholine receptor-specific T cells in patients was found specific T-cell lines could be inhibited by preincubation of APCs with anti-DR mAb. For the other two S100β-specific to be similar to that in controls (Sommer et al., 1991; Melms et al., 1992) . Therefore, frequency analyses of circulating T-cell lines, the MHC restriction element could not be identified, neither by blocking with anti-MHC antibodies nor (peripheral) T cells do not allow conclusions on the pathogenicity of human autoreactive T cells. In contrast, by using HLA-DR-matched Epstein-Barr virus-transformed B-cell lines or DR-transfected L cells as APCs. This finding comparing the relative frequency of T-cell responses to different antigens helps to obtain an estimate of the reveals further parallels with the Lewis rat in which a considerable number of S100β-specific T-cell lines could not immunogenicity of different antigens.
The frequency of S100β-specific T-cell responses was only be blocked with an anti-RT1B (anti-MHC class II) antibody (C.L., unpublished observations). 50% of that obtained for MBP, and the proliferative response induced by S100β was consistently lower than that seen for One possible explanation for the failure to block proliferation by incubation of APCs with anti-MHC antibody MBP-specific responses. Furthermore, in some patients and healthy donors, no S100β-specific T-cell responses could be would be autopresentation of antigen by T cells. This seems unlikely, however, since inhibition could not even be achieved observed ( Table 2 ). The greater difficulty in obtaining S100β-specific T cells as compared with MBP-specific T cells could when the blocking mAb were present throughout the assay. Another possibility, which is difficult to rule out, is that the indicate that the immune response against S100β is under tighter regulatory control than that against MBP. In this anti-MHC antibodies (especially the anti-DQ and anti-DP antibody) did not bind or functionally inhibit the relevant regard, it is possible that the absolute frequency of circulating S100β-specific T cells is lower than that of MBP-and PPDrestriction element(s). A third, highly speculative possibility is that the two apparently non-MHC-restricted T-cell lines specific T cells, or that the threshold for activation of S100β-specific T cells in vitro is higher. Considering the abundant (N2.40 and P1.S100β) were stimulated by an unconventional mechanism or restriction element. expression of calcium-binding S100β-like proteins in many tissues outside the CNS (Zimmer et al., 1995) , it would not
In summary, we have demonstrated that autoreactive CD4ϩ T cells specific for S100β are present in the human immune be surprising if powerful tolerance-inducing and -maintaining mechanisms exist to keep autoreactive S100β-specific T cells repertoire, but they are apparently under tighter regulatory control than MBP-specific T cells. This observation plus the in a dormant state. Based on these considerations, we postulate that the difficulties in selecting S100β-specific T cells in vitro, functional similarities between human and rat S100β-specific T-cell lines, which are known to induce EAP, suggests in part, reflect the strict regulation of these cells in vivo.
In their phenotype and cytokine production, S100β-specific that human S100β-specific T-cell lines are also potentially encephalitogenic. Although our survey showed no evidence T cells were similar to MBP-specific T cells; both express the CD4ϩ, CD8-, T-cell receptor αβϩ membrane phenotype that circulating S100β-specific T-cell lines are increased in patients with multiple sclerosis, or multiple sclerosis variants, and secrete IFN-γ, TNF-α, IL-10 and IL-4. Overall, the Tcell response to S100β, like that to MBP, seems to show a this by no means excludes a pathogenic role for S100β-specific T-cell lines during some stage of multiple sclerosis TH1-like cytokine profile, with high levels of IFN-γ and TNF-α, moderate levels of IL-10 and low levels of IL-4. [It and other inflammatory encephalopathies. An increasingly better understanding of the complex T-cell response in should be noted, that the distinction between T-helper type 1 (TH1) and type 2 (TH2) cells is not absolute in humans; multiple sclerosis should facilitate the development of more specific immunotherapies (Compston, 1994; Fairchild et al. , human TH1 cells commonly produce moderate amounts of IL-10 and small amounts of 1994; Hohlfeld, 1997). As seen in Table 4 , the kinetics of cytokine secretion varied somewhat between the different cytokines and T-cell
